Trade Summary

3 days ago, Soergel David, serving as Chief Medical Officer at Madrigal Pharmaceuticals, Inc. (MDGL), sold 844 shares at $515.90 per share, for a total transaction value of $435,420.00. Following this transaction, Soergel David now holds 11,075 shares of MDGL.

This sale represents a 7.00% decrease in Soergel David's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 18, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 18, 2026 at 5:36 PM ET, meaning the disclosure happened on the same day as the trade.

Madrigal Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.